JOHNSON & JOHNSON

Official Publications Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
146.8 ^USD	-1.15%		+0.74%	-6.33%

Apr. 25	Redburn Atlantic Adjusts Johnson & Johnson Price Target to $160 From $170	MT
Apr. 24	Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset	DJ

Official Publications

SEC Filing 8K	Apr. 15	CO
Slide show Q1	Apr. 15	CO
1st quarter results	Apr. 15	CO
SEC Filing 13G	Apr. 09	CO
Proxy Statments	Mar. 12	CO
SEC Filing 10K	Feb. 15	CO
SEC Filing 13G	Jan. 23	CO
SEC Filing 8K	Jan. 22	CO
Slide show results	Jan. 22	CO
Annual results	Jan. 22	CO
SEC Filing 8K	Dec. 04	CO
SEC Filing 8K	Nov. 29	CO
SEC Filing 8K	Nov. 20	CO
SEC Filing 10Q-3	23-10-26	CO
SEC Filing 8K	23-10-19	CO
Slide show Q3	23-10-16	CO
3rd quarter results	23-10-16	CO
SEC Filing 8K	23-10-16	CO
SEC Filing 8K	23-08-29	CO
SEC Filing 8K	23-08-22	CO
SEC Filing 10Q-2	23-07-30	CO
SEC Filing 8K	23-07-27	CO
1st-half-year results	23-07-19	CO
SEC Filing 8K	23-07-19	CO
SEC Filing 8K	23-05-02	CO

1 2 3

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer